###begin article-title 0
Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway
###end article-title 0
###begin p 1
Conceived and designed the experiments: HHZ JH KD RMS BDM. Performed the experiments: HHZ JH KD BB SW RMS CLW. Analyzed the data: HHZ JH KD RMS CLW BDM. Wrote the paper: HHZ BDM.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
The signaling pathways imposing hormonal control over adipocyte differentiation are poorly understood. While insulin and Akt signaling have been found previously to be essential for adipogenesis, the relative importance of their many downstream branches have not been defined. One direct substrate that is inhibited by Akt-mediated phosphorylation is the tuberous sclerosis complex 2 (TSC2) protein, which associates with TSC1 and acts as a critical negative regulator of the mammalian target of rapamycin (mTOR) complex 1 (mTORC1). Loss of function of the TSC1-TSC2 complex results in constitutive mTORC1 signaling and, through mTORC1-dependent feedback mechanisms and loss of mTORC2 activity, leads to a concomitant block of Akt signaling to its other downstream targets.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 712 716 708 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
###xml 809 817 <span type="species:ncbi:9606">patients</span>
We find that, despite severe insulin resistance and the absence of Akt signaling, TSC2-deficient mouse embryo fibroblasts and 3T3-L1 pre-adipocytes display enhanced adipocyte differentiation that is dependent on the elevated mTORC1 activity in these cells. Activation of mTORC1 causes a robust increase in the mRNA and protein expression of peroxisome proliferator-activated receptor gamma (PPARgamma), which is the master transcriptional regulator of adipocyte differentiation. In examining the requirements for different Akt-mediated phosphorylation sites on TSC2, we find that only TSC2 mutants lacking all five previously identified Akt sites fully block insulin-stimulated mTORC1 signaling in reconstituted Tsc2 null cells, and this mutant also inhibits adipogenesis. Finally, renal angiomyolipomas from patients with tuberous sclerosis complex contain both adipose and smooth muscle-like components with activated mTORC1 signaling and elevated PPARgamma expression.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
This study demonstrates that activation of mTORC1 signaling is a critical step in adipocyte differentiation and identifies TSC2 as a primary target of Akt driving this process. Therefore, the TSC1-TSC2 complex regulates the differentiation of mesenchymal cell lineages, at least in part, through its control of mTORC1 activity and PPARgamma expression.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 216 219 212 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Peng1">[1]</xref>
###xml 220 223 216 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Yun1">[3]</xref>
###xml 318 321 314 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Xu1">[4]</xref>
###xml 506 509 502 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Kohn1">[5]</xref>
###xml 103 108 <span type="species:ncbi:10090">Mouse</span>
The ser/thr kinase Akt (or protein kinase B/PKB) plays an essential role in adipocyte differentiation. Mouse embryonic fibroblasts (MEFs) lacking Akt1 (PKBalpha) display an inability to differentiate into adipocytes [1]-[3], and an RNAi-mediated decrease in Akt1 was found to block the differentiation of 3T3-L1 cells [4], a well-established preadipocyte cell line. Furthermore, constitutively active Akt can promote the differentiation of 3T3-L1 cells into adipocytes, even in the absence of other inputs [5]. While it is clear from these studies that Akt is both necessary and sufficient to drive adipogenesis, its downstream targets involved in regulating this differentiation program are not well understood.
###end p 9
###begin p 10
###xml 114 117 114 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Manning1">[6]</xref>
###xml 444 447 436 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Peng1">[1]</xref>
###xml 449 452 441 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Baudry1">[2]</xref>
###xml 454 457 446 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Xu1">[4]</xref>
###xml 631 634 619 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Rosen1">[7]</xref>
###xml 815 818 795 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Peng1">[1]</xref>
Akt phosphorylates and regulates a large number of substrates involved in a diverse array of biological processes [6], many of which could contribute to the role of Akt in driving adipocyte differentiation. Ultimately, the differentiation defect in MEFs and 3T3-L1 preadipocytes lacking Akt1 stems from an inability to induce peroxisome proliferator-activated receptor gamma (PPARgamma) expression at the initiation of the adipogenesis program [1], [2], [4]. The PPARgamma transcription factor is the master regulator of adipocyte differentiation, and like Akt1, its activation is both necessary and sufficient for differentiation [7]. Supporting an essential role for PPARgamma induction downstream of Akt1, forced expression of PPARgamma in Akt-deficient MEFs was found to rescue their severe adipogenesis defect [1].
###end p 10
###begin p 11
###xml 391 394 387 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Nakae1">[8]</xref>
###xml 585 588 577 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Nakae1">[8]</xref>
###xml 671 674 659 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Armoni1">[9]</xref>
At least two downstream branches of Akt signaling have been implicated in the regulation of PPARgamma expression and adipocyte differentiation. The forkhead box O (FOXO) family of transcription factors are phosphorylated and inhibited by Akt. Amongst FOXO family members, FOXO1 expression is highest in adipose tissue, but FOXO1 appears to be a strong inhibitor of adipocyte differentiation [8]. An active mutant of FOXO1 that cannot be phosphorylated and inhibited by Akt was found to block the differentiation of preadipocytes, and this correlated with a loss of PPARgamma induction [8]. Furthermore, FOXO1 has been proposed to directly repress PPARgamma transcription [9]. Taken together, these studies suggest that Akt-mediated inhibition of FOXO1 is one mechanism by which Akt induces PPARgamma and subsequent adipocyte differentiation.
###end p 11
###begin p 12
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Wullschleger1">[10]</xref>
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Bell1">[11]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Yeh1">[16]</xref>
###xml 494 498 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Cho1">[12]</xref>
###xml 499 503 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Kim1">[15]</xref>
###xml 635 639 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Kim1">[15]</xref>
###xml 828 832 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Um1">[17]</xref>
###xml 834 838 826 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-LeBacquer1">[18]</xref>
###xml 656 661 <span type="species:ncbi:10090">mouse</span>
Another major signaling branch downstream of Akt results in activation of the mammalian target of rapamycin (mTOR), a critical regulator of mRNA translation and cell growth [10]. Primarily through use of the mTOR-specific inhibitor rapamycin, several studies have concluded that mTOR activity is required for proper differentiation of preadipocyte cell lines and primary cultures [11]-[16]. The effects of rapamycin were found to correlate with a reduction in PPARgamma mRNA and protein levels [12]-[15]. Transcriptional reporter assays in HEK293 cells suggested that rapamycin might also inhibit insulin-stimulated PPARgamma activity [15]. Interestingly, mouse knockouts affecting specific mTORC1 targets suggest that both S6K1 activation and 4E-BP1/2 inhibition might contribute to a pro-adipogenic role for mTORC1 activation [17], [18].
###end p 12
###begin p 13
###xml 65 69 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Bhaskar1">[19]</xref>
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Huang1">[20]</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Inoki1">[21]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Manning2">[22]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Garami1">[23]</xref>
###xml 531 535 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Zhang1">[28]</xref>
###xml 785 789 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Kovacina1">[29]</xref>
###xml 914 918 914 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Sancak1">[30]</xref>
###xml 919 923 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Wang2">[36]</xref>
###xml 1064 1068 1064 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Sancak1">[30]</xref>
###xml 1070 1074 1070 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-VanderHaar1">[31]</xref>
###xml 1268 1272 1268 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-HahnWindgassen1">[37]</xref>
###xml 1488 1492 1488 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Harrington1">[38]</xref>
###xml 1550 1554 1550 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Li1">[39]</xref>
###xml 1555 1559 1555 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Berg1">[43]</xref>
The signaling relationship between Akt and mTOR is quite complex [19], [20]. Akt activity results in downstream activation of mTOR complex 1 (mTORC1), which is acutely sensitive to rapamycin. Akt has been proposed to activate mTORC1 through multiple mechanisms. The first is through direct multi-site phosphorylation and inhibition of TSC2 [21], [22]. TSC2, when complexed with its binding partner TSC1, acts as a GTPase activating protein (GAP) for the Ras-related small G protein Rheb, which is a potent activator of mTORC1 [23]-[28]. Therefore, Akt-mediated phosphorylation of TSC2 relieves its ability to act as a GAP for Rheb within cells, allowing Rheb-GTP to accumulate and activate mTORC1. A parallel mechanism appears to be through phosphorylation of the Akt substrate PRAS40 [29]. PRAS40 has been found by several groups to associate with mTORC1, either as a regulatory component or downstream substrate [30]-[36]. Two studies have demonstrated that the previously characterized Akt phosphorylation site on PRAS40 is involved in mTORC1 activation by Akt [30], [31]. Finally, a more indirect and less acute effect of Akt activation on mTORC1 has been proposed to be through the effects of Akt on glucose uptake, intracellular energy levels, and AMPK activity [37]. Importantly, while mTORC1 is clearly downstream of Akt, its activation can lead to feedback inhibition of insulin signaling to Akt through effects on the insulin-receptor substrate (IRS) proteins (reviewed in ref. [38]). Therefore, as originally characterized in 3T3-L1 cells [39]-[43], short-term rapamycin treatment can increase Akt activation in response to insulin in adipocytes and many other cell types.
###end p 13
###begin p 14
###xml 195 199 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Sarbassov1">[44]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Sarbassov2">[45]</xref>
###xml 492 496 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Cho1">[12]</xref>
###xml 835 839 835 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Polak1">[46]</xref>
A second mTOR-containing protein complex, mTORC2, lies upstream of Akt and contributes to Akt activation by insulin and growth factors by phosphorylating S473 in its hydrophobic regulatory motif [44]. mTORC2 is resistant to the acute effects of rapamycin, but prolonged treatment with rapamycin disrupts mTORC2 and in some lines results in loss of Akt phosphorylation [45]. To this end, prolonged rapamycin treatment has been found to block Akt signaling in differentiating 3T3-L1 adipocytes [12], suggesting that some of the previous findings regarding the effects of rapamycin treatment on adipocyte differentiation could be through loss of mTORC2-mediated Akt activation, rather than inhibition of mTORC1. However, a recent study using siRNAs to the mTORC1-specific component Raptor have supported a role for mTORC1 in adipogenesis [46].
###end p 14
###begin p 15
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC1</italic>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2</italic>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Crino1">[47]</xref>
###xml 293 297 293 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2</italic>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Carsillo1">[48]</xref>
###xml 988 992 988 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2</italic>
###xml 999 1003 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Karbowniczek1">[49]</xref>
###xml 435 440 <span type="species:ncbi:9606">women</span>
###xml 597 605 <span type="species:ncbi:9606">patients</span>
TSC1 and TSC2 are tumor suppressor genes that are mutated in the autosomal dominant tumor syndrome tuberous sclerosis complex (TSC), which is characterized by widespread benign tumors and a high incidence of epilepsy, autism spectrum disorders, and cognitive deficits (reviewed in ref. [47]). TSC2 mutations are also the underlying cause of lymphangioleiomyomatosis (LAM [48]), a proliferative disorder that almost exclusively affects women and results in cystic destruction of the lungs. Due to loss of function of the TSC1-TSC2 complex and its GAP activity toward Rheb, lesions from TSC and LAM patients display constitutively elevated mTORC1 signaling. Interestingly, renal angiomyolipomas (AMLs), which are unusual highly vascular tumors comprised of both aberrant smooth muscle cells and adipocytes, are amongst the most common clinical manifestation of the TSC and LAM diseases. Within AMLs, both the smooth muscle and adipose components display loss of heterozygosity (LOH) at the TSC2 locus [49], demonstrating that both cell types are constituents of the tumor rather than stromal derivatives. This pathological observation might be linked to a role for mTORC1 in driving mesenchymal cell differentiation.
###end p 15
###begin p 16
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc1</italic>
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Jaeschke1">[50]</xref>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Kwiatkowski1">[51]</xref>
###xml 413 417 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Jaeschke1">[50]</xref>
###xml 419 423 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Zhang2">[52]</xref>
###xml 424 428 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Shah1">[54]</xref>
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Huang2">[55]</xref>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Shah1">[54]</xref>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Manning3">[56]</xref>
###xml 671 675 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Zhang3">[57]</xref>
###xml 735 738 735 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 731 738 731 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc1<sup>&#8722;/&#8722;</sup></italic>
###xml 747 750 747 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 743 750 743 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 965 969 965 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 1089 1093 1085 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 1159 1162 1155 1158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1155 1162 1151 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 1399 1407 <span type="species:ncbi:9606">patients</span>
In this study, we take advantage of the signaling changes in cell lines lacking the TSC1-TSC2 complex to determine whether mTORC1 signaling downstream of Akt plays an important role in adipogenesis. Previous studies have demonstrated that MEFs derived from Tsc1 or Tsc2 knockout embryos display constitutive activation of mTORC1 [50], [51], strong mTORC1-dependent feedback inhibition of insulin signaling to Akt [50], [52]-[54], and loss of mTORC2 activity [55]. Therefore, disruption of the TSC1-TSC2 complex results in Akt-independent activation of mTORC1 with concomitant loss of Akt signaling to its other downstream targets, including the FOXO proteins [54], [56], [57]. We find that, despite complete loss of Akt signaling, Tsc1-/- and Tsc2-/- MEFs display enhanced adipogenic potential, yielding insulin resistant adipocytes containing increased levels of triglycerides. A similar effect is seen in 3T3-L1 cells following stable shRNA-mediated knockdown of Tsc2. Importantly, PPARgamma mRNA and protein levels are increased in an mTORC1-dependent manner in adipocytes derived from Tsc2-deficient MEFs and 3T3-L1 cells. We find that reconstituting Tsc2-/- MEFs with a mutant of TSC2 lacking all Akt phosphorylation sites blocks insulin-stimulated mTORC1 signaling and greatly reduces adipogenesis. Finally, we find that both the aberrant smooth muscle and adipose components of AMLs from TSC patients exhibit mTORC1 activation and elevated PPARgamma expression.
###end p 16
###begin title 17
Materials and Methods
###end title 17
###begin title 18
Cell culture and constructs
###end title 18
###begin p 19
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc1</italic>
###xml 198 202 198 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 207 210 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Kwiatkowski1">[51]</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Zhang2">[52]</xref>
###xml 696 700 696 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Huang2">[55]</xref>
###xml 731 734 731 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 727 734 727 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 96 102 <span type="species:ncbi:9913">bovine</span>
###xml 264 269 <span type="species:ncbi:9606">Women</span>
###xml 385 390 <span type="species:ncbi:9606">human</span>
###xml 1065 1069 <span type="species:ncbi:9913">calf</span>
Undifferentiated MEFs were cultured in Dulbecco's Modified Eagle's medium (DMEM) with 10% fetal bovine serum. Immortalized littermate-derived pairs of wild-type and null Tsc1 (3T3 immortalized) and Tsc2 (p53-/-) MEFs were provided by D.J. Kwiatkowski (Brigham and Women's Hospital, Boston, MA) and were described previously [51], [52]. Phosphorylation site (Ser/Thr to Ala) mutants of human TSC2 were generated using QuickChange Multisite-directed Mutagenesis (Stratagene), sequence verified, and subcloned into a previously described retroviral vector (IRES-Hygro, gift of D.J. Kwiatkowski) upstream of an internal ribosome entry sequence followed by the hygromycin-resistance selectable marker [55]. Stable isogenic pools of Tsc2-/- MEFs expressing the various constructs were generated by infection with retroviruses encoding empty vector, wild-type TSC2, or the TSC2 phosphorylation-site mutants, followed by selection with hygromycin (100 microg/ml). 3T3-L1 preadipocytes were obtained from the American Type Culture Collection and maintained in DMEM with 10% calf serum prior to differentiation.
###end p 19
###begin p 20
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 172 176 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 165 171 <span type="species:ncbi:10090">murine</span>
Stable shRNA-mediated knockdown of Tsc2 expression in 3T3-L1 preadipocytes was achieved using retroviral contructs. shRNA constructs targeting firefly luciferase or murine Tsc2 (V2MM_5415) were obtained from Open Biosystems, and the shRNAs were subcloned into the mir30-based pMSCV-PM retroviral vector provided by the laboratory of S.J. Elledge (Harvard Medical School, Boston, MA). Retroviruses encoding these shRNAs were produced in HEK-293T cells and were used to infect 3T3-L1 preadipocytes. Stable shRNA-expressing pools of 3T3-L1 cells were selected with puromycin (2 microg/ml) and were used immediately for the differentiation experiments described.
###end p 20
###begin p 21
###xml 4 11 4 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006189.s001">Text S1</xref>
See Text S1 for supplemental materials and methods.
###end p 21
###begin title 22
Adipocyte differentiation and triglyceride measurements
###end title 22
###begin p 23
###xml 41 45 41 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Rosen2">[58]</xref>
###xml 57 61 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Brady1">[59]</xref>
Previously established protocols for MEF [58] and 3T3-L1 [59] adipocyte differentiation were followed and are described in brief below. For induction of MEF differentiation, at 2 days post confluence (day 0), cells were exposed to a pro-differentiation regimen of insulin (830 nM), dexamethasone (1 microM), 3-isobutyl-1-methylxanthine (IBMX, 0.5 mM), and troglitazone (5 microM). After 48 hours, cells were switched to maintenance DMEM medium containing 10% FBS and 830-nM insulin for the remaining duration of differentiation. Adipocyte differentiation parameters were measured at 7-8 days following the initiation of differentiation. For induction of 3T3-L1 cell differentiation, preadipocytes were grown to 2 days post-confluence and the medium was changed to DMEM supplemented with 10% FBS, insulin (1.7 microM), dexamethasone (1 microM), and IBMX (0.5 mM). After 48 h, the medium was replaced with maintenance medium containing DMEM supplemented with 10% FBS. The maintenance medium was changed every 48 h until the cells were utilized for experimentation (9 days from the initiation of differentiation).
###end p 23
###begin p 24
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Li2">[60]</xref>
Oil Red O staining and measurement of intracellular triglyceride levels were performed as described by others [60]. For quantification, cells were washed extensively with water to remove unbound dye, and 1-ml isopropanol was added to the stained 6-well culture plate. After 5 min, the absorbance at 510 nm of the Oil Red O extract and serially diluted Oil Red O standards were assayed by spectrophotometer. Triglyceride levels were normalized to protein concentration.
###end p 24
###begin title 25
mRNA expression analysis
###end title 25
###begin p 26
###xml 512 520 509 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006189.s002">Table S1</xref>
For gene expression analyses, RNA was isolated using the RNeasy Mini Kit (Qiagen), cDNAs were generated using the Superscript III First Strand Synthesis System for RT-PCR kit (Invitrogen), and SYBR green-based quantitative RT-PCR was performed using an Applied Biosystems 7300 Real Time PCR System. Samples were run in triplicate for each experiment and were normalized to either beta-actin or m36b4 expression to determine relative expression levels. Primer sets used in this study are provided in supplemental Table S1.
###end p 26
###begin title 27
Immunoblotting and immunohistochemistry
###end title 27
###begin p 28
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Manning2">[22]</xref>
Protein extracts/cell lysates and immunoblots were prepared as described previously [22]. All lysates were normalized for total protein concentration prior to SDS-PAGE and immunoblotting. With the exception of the beta-actin antibody (Sigma), all antibodies used for immunoblotting were obtained from Cell Signaling Technology.
###end p 28
###begin p 29
###xml 493 494 489 490 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 495 496 491 492 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 222 227 <span type="species:ncbi:9606">Human</span>
Formalin-fixed, paraffin-embedded renal AML tissue from TSC patients, and normal human adipose tissue, were obtained from the Pathology Department of Massachusetts General Hospital. This study was approved by the Hospital Human Study Committees. Serial 5-microm tissue sections were cut from each tissue block for immunohistochemical analyses using the avidin-biotin complex (ABC) method. Briefly, slides were deparaffinized and endogenous peroxidase activity was blocked by incubation in 3% H2O2 for 10 min at room temperature. For antigen retrieval, sections were heated in a pressure cooker in 10-mM citrate buffer (pH 6.0) prior to staining. Antibodies to phospho-S6 (Ser235/236; Cell Signaling Technology #2211; 1:200 dilution) and PPARgamma (Santa Cruz Biotechnology #7196; 1:100 dilution) diluted in phosphate-buffered saline (PBS) were applied and incubated overnight at 4degreesC. Negative controls included adjacent sections incubated in PBS without primary antibody. Immunodetection was performed with an LSAB 2 system (DAKO). Hematoxylin was used as a counterstain, and an adjacent section was stained with hematoxylin and eosin.
###end p 29
###begin title 30
Statistical Analysis
###end title 30
###begin p 31
###xml 170 171 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Results are expressed as the mean+/-SEM. Quantitative data for intracellular triglyceride levels were analyzed by one-way analysis of variance or paired 2-tailed Student t test using GraphPad InStat version 2.04a. Multiple comparisons were performed using Tukey's honestly significant difference procedure.
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
MEFs lacking the TSC1-TSC2 complex display enhanced mTORC1-dependent adipogenesis
###end title 33
###begin p 34
###xml 178 181 178 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 174 181 174 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc1<sup>&#8722;/&#8722;</sup></italic>
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 185 192 185 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Jaeschke1">[50]</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Zhang3">[57]</xref>
###xml 500 509 500 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006189.s003">Figure S1</xref>
###xml 801 804 801 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 797 804 797 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 889 898 889 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006189.s003">Figure S1</xref>
To determine if mTORC1 activation downstream of Akt is both necessary and sufficient to drive adipocyte differentiation, we utilized littermate pairs of wild-type and either Tsc1-/- or Tsc2-/- MEFs. Akt and mTORC1 signaling in these MEFs have been characterized in previous studies [50]-[57]. These MEFs display growth factor and Akt-independent activation of mTORC1 signaling, as indicated by phosphorylation of the ribosomal S6 protein, and complete loss of insulin-stimulated Akt phosphorylation (Figure S1, panels A and B). The defect in Akt activation and signaling to its downstream substrates is also evident in TSC2-deficient MEFs grown in full serum, as illustrated by a loss of FOXO1 phosphorylation on T24, and constitutive localization of a FOXO3a-GFP fusion protein to the nucleus in Tsc2-/- cells, similar to a mutant lacking the three Akt phosphorylation sites (FOXO3a-AAA, Figure S1, panels C and D). Therefore, these cells offer a unique setting in which mTORC1 activation can be completely separated from the many other downstream branches of Akt signaling.
###end p 34
###begin p 35
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Rosen2">[58]</xref>
###xml 279 282 279 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 275 282 275 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc1<sup>&#8722;/&#8722;</sup></italic>
###xml 291 294 291 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 287 294 287 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 301 310 301 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006189.s003">Figure S1</xref>
###xml 581 590 581 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g001">Figure 1A</xref>
###xml 595 605 595 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006189.s004">Figure S2A</xref>
###xml 646 655 646 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g001">Figure 1B</xref>
###xml 660 670 660 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006189.s004">Figure S2B</xref>
###xml 778 782 778 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 1120 1123 1112 1115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1116 1123 1108 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>+/+</sup></italic>
###xml 1132 1135 1124 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1128 1135 1120 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 1227 1230 1219 1222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1223 1230 1215 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 1238 1247 1230 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g001">Figure 1C</xref>
These MEF pairs were subjected to conditions previously established to promote differentiation of MEFs into adipocytes [58]. Importantly, even in response to the very high insulin levels utilized in this differentiation protocol (830 nM), Akt activation is defective in both Tsc1-/- and Tsc2-/- MEFs (Figure S1, panels A and B). Interestingly, despite severe insulin resistance, both knockout cell lines underwent morphological changes consistent with adipocyte differentiation and showed a greatly enhanced capacity to generate lipid droplets, as indicated by oil red O staining (Figure 1A and Figure S2A) and intracellular triglyceride levels (Figure 1B and Figure S2B), relative to their wild-type counterparts. To determine whether the increase in lipid accumulation in the Tsc2-deficient cells reflects an increase in adipogenesis, at day 7 of differentiation we measured the expression of adipocyte markers, including the adipogenic transcription factors C/EBPalpha and PPARgamma and the adipocyte-specfic cytokines leptin and adiponectin. While transcript levels for all of these markers were induced in both Tsc2+/+ and Tsc2-/- MEFs over the course of differentiation, their levels were significantly higher in the Tsc2-/- cells (Figure 1C). Therefore, cells lacking a functional TSC1-TSC2 complex display an enhanced capacity to differentiate into adipocytes.
###end p 35
###begin title 36
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
Tsc2-deficient MEFs display an mTORC1-dependent increase in adipogenesis.
###end title 36
###begin p 37
###xml 86 89 86 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 130 133 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 126 133 126 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>+/+</sup></italic>
###xml 424 427 420 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 420 427 416 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 497 500 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 493 500 489 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>+/+</sup></italic>
###xml 646 647 640 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 719 722 713 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 715 722 709 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 859 863 851 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 863 866 855 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 907 908 899 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 967 971 959 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 971 974 963 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 982 986 974 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 986 989 978 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 994 998 986 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 998 1001 990 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1374 1377 1362 1365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1370 1377 1358 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 1424 1428 1412 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 1428 1431 1416 1419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1436 1440 1424 1428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 1440 1443 1428 1431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1630 1631 1616 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1640 1641 1626 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A) Greater lipid accumulation following an adipocyte differentiation protocol in Tsc2-/- MEFs relative to littermate-derived Tsc2+/+ MEFs. MEFs of the indicated genotype were induced to differentiate for 8 days, and cells were then stained with Oil Red O. Representative culture dish wells (top) and microscopic fields of view (bottom; scale bars = 25 microm) are shown at the same magnification for each genotype. (B) Tsc2-/- adipocytes have higher levels of intracellular triglyceride than Tsc2+/+ adipocytes. Relative triglyceride levels, normalized to cellular protein content, are shown from three different experiments as the mean+/-SEM. *P<0.01. (C) Adipogenic factors and adipocyte markers are elevated in Tsc2-/- adipocytes. Relative expression of the indicated genes was determined by quantitative RT-PCR and is presented as mean+/-SEM relative to Tsc2+/+ adipocytes (day 8 of differentiation). *P<0.01. (D) Rapamycin inhibits adipocyte differentiation of Tsc2-/- cells. Tsc2+/+ and Tsc2-/- MEFs were induced to differentiate for 8 days in the presence of rapamycin (20 nM) or vehicle control (0.1% DMSO), and cells were stained with Oil Red O. Representative culture dish wells (left) and microscopic fields of view (right; scale bars = 25 microm) are shown at the same magnification for each genotype. (E) The increased intracellular triglyceride levels in Tsc2-/- adipocytes is dependent on mTORC1 activation. Tsc2+/+ and Tsc2-/- MEFs were treated as in (D), and relative triglyceride levels, normalized to cellular protein content, were determined and are shown from three different experiments as the mean+/-SEM. *P<0.01, **P<0.001.
###end p 37
###begin p 38
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Bell1">[11]</xref>
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Yeh1">[16]</xref>
###xml 169 172 169 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 165 172 165 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 257 260 257 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 253 260 253 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 361 370 361 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g001">Figure 1D</xref>
###xml 428 437 428 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g001">Figure 1E</xref>
###xml 501 504 501 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 497 504 497 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc1<sup>&#8722;/&#8722;</sup></italic>
###xml 511 521 511 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006189.s004">Figure S2B</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Huang2">[55]</xref>
Given the previous studies demonstrating that rapamycin could block adipocyte differentiation [11]-[16], we hypothesized that the enhanced adipogenesis phenotype of Tsc2-/- MEFs would be dependent on the elevated mTORC1 activity in these cells. Indeed, Tsc2-/- MEFs failed to differentiate in the presence of rapamycin, exhibiting a loss of oil red O-staining (Figure 1D) and a dramatic decrease in intracellular triglycerides (Figure 1E). This effect of rapamycin is also seen in differentiating Tsc1-/- MEFs (Figure S2B). As Akt and mTORC2 activity are already inhibited in cells lacking the TSC1-TSC2 complex [55], these findings demonstrate that the effects of rapamycin on adipocyte differentiation are specific to mTORC1.
###end p 38
###begin title 39
TSC2-deficient MEFs differentiate in an insulin-independent manner and give rise to insulin resistant adipocytes
###end title 39
###begin p 40
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Miki1">[61]</xref>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Harrington2">[53]</xref>
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Shah1">[54]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Shah2">[62]</xref>
###xml 434 437 434 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 430 437 430 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 549 552 549 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 545 552 545 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>+/+</sup></italic>
###xml 560 568 560 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g002">Figure 2</xref>
###xml 767 770 767 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 763 770 763 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 884 893 884 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g002">Figure 2B</xref>
Insulin signaling through IRS-1 and IRS-2 has been shown to be an essential element of the adipocyte differentiation program [61]. Given the down-regulation of these proteins in cells lacking the TSC1-TSC2 complex [53], [54], [62], we hypothesized that constitutive mTORC1 activation would allow these cells to differentiate independent of insulin signaling. Interestingly, even in the complete absence of differentiation medium, Tsc2-/- MEFs incubated at confluence for 7 days in normal growth medium accumulated more lipid than differentiated Tsc2+/+ cells (Figure 2, panels A and B). However, the full adipocyte differentiation medium induced a much more robust adipogenesis in these cells. Consistent with the insulin-resistant nature of Akt signaling in the Tsc2-/- MEFs, removal of insulin from the differentiation mixture only mildly reduced intracellular triglyceride levels (Figure 2B). These data suggest that a primary role of insulin and IRS protein function in adipogenesis is to stimulate the downstream activation mTORC1.
###end p 40
###begin title 41
TSC2-deficient MEFs differentiate in an insulin-independent manner and give rise to insulin resistant adipocytes.
###end title 41
###begin p 42
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 197 218 197 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 653 657 647 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 657 660 651 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 688 692 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 692 695 686 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 700 704 694 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 704 707 698 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 900 903 894 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 896 903 890 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 953 957 947 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs1</italic>
###xml 959 963 953 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs2</italic>
###xml 969 974 963 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Glut4</italic>
###xml 1106 1110 1098 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 1110 1113 1102 1105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1154 1155 1146 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1167 1172 1159 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Glut1</italic>
###xml 1241 1244 1233 1236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1237 1244 1229 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 1272 1276 1264 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 1276 1279 1268 1271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1284 1288 1276 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 1288 1291 1280 1283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1408 1413 1400 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Glut1</italic>
###xml 1512 1516 1502 1506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 1516 1519 1506 1509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
(A) Insulin-independent differentiation of Tsc2-/- MEFs. MEFs of the indicated genotype were grown to confluence and then either maintained in normal growth medium or induced to differentiate (see Materials and Methods) in the presence or absence of exogenous insulin (830 nM) for 8 days. Cells were then stained with Oil Red O. Representative fields of cells are shown (scale bars = 50 microM). (B) MEFs were treated as in (A) and relative intracellular triglyceride levels, normalized to cellular protein content, are shown from three different experiments as the mean+/-SEM. (C) Decreased IRS-1 and insulin resistant Akt activation in differentiated Tsc2-/- adipocytes. Differentiated Tsc2+/+ and Tsc2-/- adipocytes (day 8) were serum starved for 16 h and then stimulated with 100- or 830-nM insulin for 15 min prior to lysis and immunoblotting with the indicated antibodies (P-Akt-S473). (D) Tsc2-/- adipocytes express significantly lower levels of Irs1, Irs2, and Glut4 mRNAs. Relative expression of the indicated genes was determined by quantitative RT-PCR and is presented as mean+/-SEM relative to Tsc2+/+ adipocytes (day 8 of differentiation). *P<0.001. (E) Glut1 transcript levels are elevated in an mTORC1-dependent manner in Tsc2-/- adipocytes. Differentiated Tsc2+/+ and Tsc2-/- adipocytes were treated with rapamycin (20 nM) for 1 h, 12 h, or 24 h prior to determining the expression levels of Glut1 by quantitative RT-PCR. Expression levels are presented as mean+/-SEM relative to untreated (0 h) Tsc2+/+ cells. (F) Glut4 transcript levels were also measured in the samples described in (C).
###end p 42
###begin p 43
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Smith1">[63]</xref>
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Pederson1">[64]</xref>
###xml 212 215 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 208 215 208 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>+/+</sup></italic>
###xml 224 227 224 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 220 227 220 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 310 319 310 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006189.s003">Figure S1</xref>
###xml 540 549 540 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g002">Figure 2C</xref>
###xml 578 581 578 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Inr</italic>
###xml 583 588 583 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs-1</italic>
###xml 594 599 594 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs-2</italic>
###xml 623 626 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 619 626 619 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>+/+</sup></italic>
###xml 635 638 635 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 631 638 631 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 718 723 718 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs-1</italic>
###xml 728 733 728 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs-2</italic>
###xml 771 774 771 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 767 774 767 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 787 796 787 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g002">Figure 2D</xref>
###xml 940 944 940 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Harrington2">[53]</xref>
###xml 946 950 946 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Shah1">[54]</xref>
###xml 952 956 952 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Shah2">[62]</xref>
###xml 1011 1016 1011 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs-1</italic>
###xml 1021 1026 1021 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Irs-2</italic>
###xml 1077 1080 1077 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1073 1080 1073 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 1145 1148 1145 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1141 1148 1141 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>+/+</sup></italic>
###xml 1161 1170 1161 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006189.s005">Figure S3</xref>
Due to increased expression of the insulin receptor (InR) and IRS proteins, the responsiveness to insulin generally increases upon adipocyte differentiation [63], [64]. Therefore, we examined the response of Tsc2+/+ and Tsc2-/- adipocytes to overnight full serum or acute insulin. As in undifferentiated MEFs (Figure S1), Akt phosphorylation is unresponsive to both serum and insulin in Tsc2-deficient adipocytes, even at the high dose of insulin found in the differentiation mixture, and these cells contain very low IRS-1 protein levels (Figure 2C). While the transcripts for Inr, Irs-1, and Irs-2 are all induced in Tsc2+/+ and Tsc2-/- cells during differentiation, their relative expression levels, especially for Irs-1 and Irs-2, were significantly lower in the Tsc2-/- adipocytes (Figure 2D). Consistent with previous studies demonstrating that chronic mTORC1 activation decreases both the expression and stability of IRS-1 and IRS-2 [53], [54], [62], we find that 24 h treatment with rapamycin increases Irs-1 and Irs-2 transcript levels and IRS-1 protein levels in Tsc2-/- adipocytes, albeit to levels still significantly lower than Tsc2+/+ adipocytes (Figure S3, panels A and B).
###end p 43
###begin p 44
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Huang3">[65]</xref>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Shepherd1">[66]</xref>
###xml 543 549 543 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Glut-4</italic>
###xml 607 610 607 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 603 610 603 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 705 708 705 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 701 708 701 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 732 735 732 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 728 735 728 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>+/+</sup></italic>
###xml 748 757 748 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g002">Figure 2D</xref>
###xml 790 794 790 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 985 989 985 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Garvey1">[67]</xref>
###xml 991 995 991 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Garvey2">[68]</xref>
###xml 1167 1171 1167 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Pedersen1">[69]</xref>
###xml 1178 1184 1178 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Glut-1</italic>
###xml 1340 1344 1332 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Brugarolas1">[70]</xref>
###xml 1346 1350 1338 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Brugarolas2">[71]</xref>
###xml 1396 1402 1388 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Glut-1</italic>
###xml 1458 1461 1450 1453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1454 1461 1446 1453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 1564 1573 1556 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g002">Figure 2E</xref>
###xml 1623 1629 1615 1621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Glut-4</italic>
###xml 1642 1651 1634 1643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g002">Figure 2F</xref>
###xml 1686 1690 1678 1682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
GLUT-4 is a glucose transporter whose translocation to the plasma membrane is regulated by insulin-stimulated Akt signaling (reviewed in reference [65]). GLUT-4 is transcriptionally up-regulated during adipocyte differentiation in order to assure that glucose uptake into adipose tissue is tightly coupled to the insulin response. However, GLUT-4 levels have been found to be decreased in the adipose tissue of a variety of rodent models of insulin resistance (e.g., reviewed in reference [66]). Interestingly, unlike other adipocyte markers, Glut-4 transcript levels are not induced in differentiating Tsc2-/- cells, with expression levels being approximately five-fold lower in fully differentiated Tsc2-/- adipocytes than in Tsc2+/+ adipocytes (Figure 2D). The increased lipid levels in Tsc2-deficient adipocytes indicate that these cells must possess alternative mechanisms of carbon/glucose uptake. Previous studies have suggested that, along with a decrease in GLUT-4 expression [67], [68], conditions of obesity and insulin resistance can be accompanied by increased expression of the constitutive glucose transporter GLUT-1 in adipose tissue (e.g., reference [69]). The Glut-1 gene is a target of the hypoxia-inducible factor-1alpha (HIF1alpha) transcription factor, which is upregulated by mTORC1 signaling in TSC-deficient cells ([70], [71]; K.D. and B.D.M., unpublished data). Indeed, Glut-1 transcript levels were found to be elevated in the Tsc2-/- adipocytes relative to their wild-type counterparts, and rapamycin treatment blocked this expression (Figure 2E). However, rapamycin had only minimal effects on Glut-4 expression (Figure 2F). These findings demonstrate that Tsc2-deficient adipocytes are insulin resistant and mimic some aspects of insulin resistant adipose tissue from rodent models, including down-regulation of IRS proteins and GLUT-4 and increased expression of GLUT-1.
###end p 44
###begin title 45
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
Tsc2 knockdown in 3T3-L1 preadipocytes enhances adipogenesis
###end title 45
###begin p 46
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 333 337 333 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 484 493 484 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g003">Figure 3A</xref>
###xml 740 743 740 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 736 743 736 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc1<sup>&#8722;/&#8722;</sup></italic>
###xml 752 755 752 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 748 755 748 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 762 766 762 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 835 844 835 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g003">Figure 3B</xref>
###xml 889 898 889 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g003">Figure 3C</xref>
###xml 996 1000 996 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
In order to further confirm the role of the TSC1-TSC2 complex and mTORC1 in regulating adipocyte differentiation, we utilized 3T3-L1 preadipocytes as a well-established model for this process. We generated 3T3-L1 cells stably expressing shRNAs targeting Tsc2 or firefly luciferase as a control. Efficient shRNA-mediated knockdown of Tsc2 leads to constitutive activation of mTORC1 in 3T3-L1 preadipocytes, as detected by increased basal phosphorylation of its downstream target S6K1 (Figure 3A). Furthermore, these cells exhibit mTORC1-driven insulin resistance, as detected by a decrease in the insulin-stimulated phosphorylation of Akt, which is rescued by pre-treatment with rapamycin. Consistent with the findings in differentiated Tsc1-/- and Tsc2-/- MEFs, Tsc2 knockdown yields adipocytes displaying enhanced oil red O staining (Figure 3B) and increased intracellular triglycerides (Figure 3C) relative to control cells. As expected, rapamycin blocks lipid accumulation in both control and Tsc2 knockdown cells, further demonstrating an essential role for mTORC1 in adipogenesis.
###end p 46
###begin title 47
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
shRNA-mediated knockdown of Tsc2 expression in 3T3-L1 preadipocytes leads to enhanced mTORC1-dependent adipocyte differentiation.
###end title 47
###begin p 48
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 715 719 715 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 1049 1053 1045 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 1427 1428 1421 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1437 1438 1431 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1448 1449 1442 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
(A) 3T3-L1 preadipocytes with stable shRNA-mediated knockdown of Tsc2 expression display elevated basal mTORC1 signaling and attenuation of insulin-stimulated Akt phosphorylation. 3T3-L1 preadipocytes stably expressing shRNAs targeting Tsc2 (shTsc2), or firefly luciferase (shLuc) as a control, were serum-starved for 16 h and, where indicated, were pretreated with rapamycin for 15 min prior to stimulation with 100-nM insulin for 15 min. Lysates were immunoblotted for the indicated phosphorylated (P-Akt (S473), P-S6K1 (T389)) or total proteins with eIF4E levels provided as a loading control. (B) Enhanced mTORC1-dependent adipocyte differentiation of 3T3-L1 preadipocytes following shRNA-mediated knockdown of Tsc2. 3T3-L1 preadipocytes expressing shLuc or shTsc2 were induced to differentiate for 9 days in the presence or absence of rapamycin (20 nM), and cells were then stained with Oil Red O. Representative microscopic fields of view (scale bars = 25 microm) are shown at the same magnification for cell line and treatment. (C) Decreased Tsc2 expression in 3T3-L1 adipocytes results in an mTORC1-dependent increase in intracellular triglyceride levels. 3T3-L1 preadipocytes expressing shLuc or shTsc2 were treated as in (C), and relative triglyceride levels, normalized to cellular protein content, were determined and are shown from three different experiments as the mean+/-SEM relative to levels in shLuc cells. *P<0.05, **P<0.01, ***P<0.001.
###end p 48
###begin title 49
mTORC1 drives PPARgamma mRNA expression
###end title 49
###begin p 50
###xml 195 199 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Rosen3">[72]</xref>
###xml 353 356 345 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 349 356 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>+/+</sup></italic>
###xml 363 371 355 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g004">Figure 4</xref>
###xml 390 395 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pparg</italic>
###xml 441 445 433 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 537 546 529 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g004">Figure 4A</xref>
###xml 558 563 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cebpa</italic>
###xml 630 633 622 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 626 633 618 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>+/+</sup></italic>
###xml 642 645 634 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 638 645 630 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 653 662 645 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g004">Figure 4B</xref>
###xml 819 828 811 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g004">Figure 4C</xref>
###xml 907 910 895 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 903 910 891 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 932 935 920 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 928 935 916 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>+/+</sup></italic>
###xml 1338 1347 1315 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g004">Figure 4C</xref>
###xml 1493 1497 1466 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 1499 1508 1472 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g004">Figure 4D</xref>
###xml 1541 1544 1514 1517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1537 1544 1510 1517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 1613 1622 1582 1591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g004">Figure 4E</xref>
###xml 1640 1649 1609 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g004">Figure 4F</xref>
###xml 1844 1849 1813 1818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pparg</italic>
In order to explore the mechanism of mTORC1-driven adipogenesis, we focused on components of the well-known transcriptional cascade underlying this differentiation program (reviewed in reference [72]). In differentiation medium, transcript levels for the adipogenic transcription factors PPARgamma and C/EBPalpha peak at day 2 of differentiation in Tsc2+/+ MEFs (Figure 4, panels A and B). Pparg transcript levels are strikingly elevated in Tsc2-deficient MEFs, even at day 0 of differentiation, and remain high throughout adipogenesis (Figure 4A). However, Cebpa transcript levels follow a similar pattern in differentiating Tsc2+/+ and Tsc2-/- cells (Figure 4B). The protein levels of the major adipogenic transcription factors were examined following 48 h of differentiation in the presence or absence of rapamycin (Figure 4C). Of these factors, only PPARgamma levels are elevated in differentiating Tsc2-/- MEFs relative to Tsc2+/+ MEFs, and in fact, C/EBPbeta and delta levels are decreased in these cells. Importantly, the increase in PPARgamma levels is sensitive to rapamycin. It is worth noting that the levels of FOXO family members are similar in wild-type and Tsc2 null cells at this stage of differentiation, and consistent with loss of Akt signaling, these transcription factors remain hypophosphorylated in the null cells (Figure 4C). An mTORC1-dependent increase in PPARgamma is also seen in the 3T3-L1 adipocytes, described above, following stable shRNA-mediated knockdown of Tsc2 (Figure 4D). Prior to differentiation, Tsc2-/- MEFs express greatly elevated levels of both the PPARgamma protein (Figure 4E) and transcript (Figure 4F), and these are dependent on elevated mTORC1 signaling, as indicated by their sensitivity to rapamycin. Therefore, loss of the TSC genes results in an mTORC1-driven transcriptional induction of Pparg, resulting in elevated levels of PPARgamma protein and an enhanced adipogenic program.
###end p 50
###begin title 51
mTORC1 activation triggers a large increase in PPARgamma mRNA and protein levels.
###end title 51
###begin p 52
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pparg</italic>
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 178 199 178 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 202 207 202 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pparg</italic>
###xml 355 359 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 359 362 357 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 373 378 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cebpa</italic>
###xml 494 498 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 498 501 492 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 539 543 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 543 546 537 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 551 555 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 555 558 549 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 870 874 860 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 1201 1204 1187 1190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1197 1204 1183 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 1232 1235 1218 1221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1228 1235 1214 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 1291 1296 1277 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pparg</italic>
###xml 1365 1368 1351 1354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1361 1368 1347 1354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 1375 1380 1361 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pparg</italic>
###xml 1470 1473 1456 1459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1466 1473 1452 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 1579 1582 1565 1568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
(A) Pparg transcript levels are elevated in Tsc2-/- MEFs before and during adipocyte differentiation. Tsc2+/+ and Tsc2-/- MEFs were induced to differentiate into adipocytes (see Materials and Methods). Pparg transcript levels were measured at days 0, 2, 4, and 7 of differentiation by quantitative RT-PCR and are presented as mean+/-SEM relative to day 0 Tsc2+/+ MEFs. (B) Cebpa transcript levels are shown in the samples from (A). (C) PPARgamma protein levels are increased in differentiating Tsc2-/- cells in an mTORC1-dependent manner. Tsc2+/+ and Tsc2-/- MEFs were induced to differentiate for 48 h in the presence or absence of rapamycin (20 nM). Cell lysates were then immunoblotted for levels of phosphorylated (P-S6K1 (T389)) or total proteins, with eIF4E provided as a loading control. (D) PPARgamma protein levels are elevated in an mTORC1-dependent manner in Tsc2-knockdown 3T3-L1 adipocytes. 3T3-L1 preadipocytes expressing shLuc or shTsc2 were induced to differentiate for 9 days in the presence or absence of rapamycin (20 nM) prior to immunoblotting with the indicated antibodies. (E) Prior to differentiation, PPARgamma protein levels are elevated in an mTORC1-dependent manner in Tsc2-/- MEFs. Where indicated, Tsc2-/- MEFs were treated for 24 h with rapamcyin (20 nM). (F) Pparg transcript levels are elevated in an mTORC1-dependent manner in Tsc2-/- MEFs. Pparg transcript levels were measured in confluent undifferentiated MEFs. Where indicated, Tsc2-/- MEFs were treated for 24 h with rapamcyin (20 nM). Quantitative RT-PCR results are normalized to the Tsc2+/+ control siRNA samples.
###end p 52
###begin title 53
Akt-mediated phosphorylation and inhibition of TSC2 promotes adipogenesis
###end title 53
###begin p 54
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 375 384 375 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g005">Figure 5A</xref>
###xml 386 390 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Inoki1">[21]</xref>
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Manning2">[22]</xref>
###xml 536 546 536 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Potter1">[73]</xref>
###xml 683 695 683 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S939A/T1462A</sup>
###xml 785 789 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Manning2">[22]</xref>
###xml 977 981 977 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Inoki1">[21]</xref>
###xml 983 987 983 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Cai1">[74]</xref>
###xml 1218 1221 1218 1221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1214 1221 1214 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 1256 1260 1256 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2</italic>
###xml 1262 1269 1262 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2-2A</italic>
###xml 1337 1369 1337 1369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S939A/S981A/S1130A/S1132A/T1462A</sup>
###xml 1391 1398 1391 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2-5A</italic>
###xml 1465 1469 1465 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2</italic>
###xml 1672 1681 1672 1681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g005">Figure 5B</xref>
###xml 536 546 <span type="species:ncbi:7227">Drosophila</span>
Given the well-defined signaling changes in Tsc2-/- cells, where constitutive mTORC1 signaling is accompanied by loss of Akt activity, the above data strongly suggest that mTORC1 activation downstream of Akt is sufficient to drive adipogenesis. A primary mechanism by which Akt activates mTORC1 is through phosphorylation and inhibition of TSC2 within the TSC1-TSC2 complex (Figure 5A; [21], [22]). Akt has been found to phosphorylate four or five distinct sites on TSC2, but only two of these sites are conserved and phosphorylated in Drosophila TSC2 (S939 and T1462; [73]). Previous studies have found that overexpression of a mutant of TSC2 lacking these two conserved sites (TSC2S939A/T1462A, referred to here as TSC2-2A) can dominantly inhibit insulin-stimulated mTORC1 signaling [22]. However, in similar overexpression studies in wild-type cells, roles for the additional phosphorylation sites, which are conserved in TSC2 from all vertebrates, have also been suggested [21], [74]. In order to more rigorously test the relative importance of these phosphorylation sites under conditions where TSC2 is expressed at more physiological levels without interference from endogenous TSC2, we stably reconstituted Tsc2-/- MEFs with empty vector, wild-type TSC2, TSC2-2A, or a mutant lacking all five previously identified Akt sites (TSC2S939A/S981A/S1130A/S1132A/T1462A, referred to here as TSC2-5A) via retrovirus infection. As expected, introduction of wild-type TSC2 or the phosphorylation-site mutants blocked mTORC1-dependent feedback effects on IRS-1, as detected by decreased S307 phosphorylation, increased electrophoretic mobility, and increased levels of IRS-1 (Figure 5B). Reflecting differential effects on mTORC1 signaling, the TSC2-5A mutant renders a more complete loss of S307 phosphorylation and downshift of the IRS-1 protein than wild-type TSC2 or the TSC2-2A mutant. Acute insulin stimulation of Akt phosphorylation was restored in the three TSC2-reconstituted lines but not in cells expressing empty vector, which remained insulin resistant.
###end p 54
###begin title 55
Akt-mediated phosphorylation of TSC2 is essential for insulin-stimulated mTORC1 signaling and is required for proper adipocyte differentiation.
###end title 55
###begin p 56
###xml 456 466 456 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 622 632 622 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 709 713 709 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 739 743 739 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2</italic>
###xml 745 752 745 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2-2A</italic>
###xml 757 764 757 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2-5A</italic>
###xml 839 843 839 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 843 846 843 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1163 1173 1163 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1375 1379 1375 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 1379 1382 1379 1382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1683 1686 1679 1682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1679 1686 1675 1682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 2001 2002 1995 1996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2021 2022 2015 2016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2043 2044 2037 2038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2123 2126 2113 2116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2119 2126 2109 2116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 456 466 <span type="species:ncbi:7227">Drosophila</span>
###xml 622 632 <span type="species:ncbi:7227">Drosophila</span>
###xml 1163 1173 <span type="species:ncbi:7227">Drosophila</span>
(A) Model of insulin stimulation of mTORC1 signaling via Akt-mediated phosphorylation of TSC2 (Top). Akt activation downstream of IRS1/2 and PI3K leads to phosphorylation and inhibition of TSC2, thereby relieving its inhibition of mTORC1 signaling. Consequent activation of mTORC1 leads to inhibition of 4E-BP, activation of S6K, and S6K-mediated feedback inhibition of IRS1/2. Akt phosphorylates TSC2 on five sites (bottom), two of which are conserved in Drosophila (depicted in black) and three of which are specific to vertebrate TSC2 (depicted in purple). Alanine substitution mutants affecting the sites conserved in Drosophila (TSC2-2A) or all five sites (TSC2-5A) were generated. (B) Reconstitution of Tsc2 null MEFs with wild-type TSC2, TSC2-2A, or TSC2-5A restores IRS-1 protein levels and insulin responsive Akt phosphorylation. Tsc2-/- MEFs were reconstituted with wild-type TSC2 (WT), TSC2-2A (2A), or TSC2-5A (5A) via retroviral infection. Stable pools were serum-starved overnight and stimulated with insulin (100 nM) for 30 minutes prior to lysis and immunoblotting with the indicated antibodies. (C) Phosphorylation of both the sites conserved in Drosophila TSC2 and those specific to vertebrate TSC2 is essential for insulin stimulated mTORC1 signaling. Cells were treated as in (B). (D) The Akt phosphorylation sites on TSC2 are important for adipogenesis. Tsc2-/- MEFs stably reconstituted with wild-type TSC2 (WT), TSC2-2A (2A), or TSC2-5A (5A) were induced to differentiate into adipocytes for seven days and were stained with Oil Red O. Representative microscopic fields of view (scale bars = 25 microm) are shown. (E) Reduced intracellular triglyceride in Tsc2-/- cells reconstituted with wild-type TSC2 or the TSC2-5A mutant. Relative intracellular triglyceride levels, normalized to cellular protein content, were determined for the cells described in (D) and are shown from three different experiments as the mean+/-SEM relative to levels in the vector reconstituted cells. *P<0.01 v. vector, **P<0.001 v. vector and P<0.05 v. WT. (F) The elevated mTORC1 signaling and PPARgamma expression in Tsc2-/- MEFs is reduced by reconstitution with wild-type TSC2 or the TSC2-5A mutant. The stably reconstituted pools of MEFs described in (B) were lysed at day 0 of differentiation, normalized for total protein, and immunoblotted with the indicated antibodies. Actin and eIF4E levels are provided as loading controls. Relative levels of PPARgamma were determined by quantification of band intensity, normalized to actin, using the ImageJ software, and values are expressed relative to the wild-type TSC2-reconstituted cells.
###end p 56
###begin p 57
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 258 267 258 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g005">Figure 5C</xref>
###xml 597 607 597 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 597 607 <span type="species:ncbi:7227">Drosophila</span>
Both wild-type TSC2 and the phosphorylation-site mutants blocked the constitutive, growth factor-independent mTORC1 activity in Tsc2-deficient cells, as monitored by S6K1 and S6 phosphoryation and 4E-BP1 mobility shifts indicative of phosphorylation status (Figure 5C). Cells expressing wild-type TSC2 displayed insulin-stimulated mTORC1 signaling, while the TSC2-2A mutant partially attenuated this response. Importantly, mTORC1 signaling was unresponsive to insulin in cells expressing the TSC2-5A mutant, demonstrating that the additional phosphorylation sites on vertebrate TSC2, not found on Drosophila TSC2, are essential for Akt-mediated activation of mTORC1.
###end p 57
###begin p 58
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 117 124 117 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 312 320 312 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g001">Figure 1</xref>
###xml 327 330 327 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 323 330 323 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 365 369 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2</italic>
###xml 495 503 495 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g005">Figure 5</xref>
###xml 541 544 541 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 537 544 537 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 573 580 573 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2-5A</italic>
###xml 661 670 661 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g005">Figure 5D</xref>
###xml 774 783 774 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g005">Figure 5E</xref>
###xml 869 873 865 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2</italic>
###xml 907 915 903 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g004">Figure 4</xref>
###xml 983 987 975 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2</italic>
###xml 992 999 984 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2-5A</italic>
###xml 1051 1060 1043 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g005">Figure 5F</xref>
###xml 1136 1143 1128 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2-5A</italic>
###xml 1166 1175 1158 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g005">Figure 5B</xref>
In order to determine the adipogenic role of TSC2 phosphorylation and inhibition by Akt, we compared the capacity of Tsc2-/- MEFs expressing empty vector, wild-type TSC2, or the TSC2-5A mutant to differentiate into adipocytes. In support of our findings with littermate-derived wild-type and TSC-deficient MEFs (Figure 1), Tsc2-/- MEFs reconstituted with wild-type TSC2 yielded fewer adipocytes with a significant reduction in intracellular triglyceride levels compared to vector control cells (Figure 5, panels D and E). Interestingly, Tsc2-/- MEFs reconstituted with the TSC2-5A mutant were further reduced in their capacity to differentiate into adipocytes (Figure 5D) and accumulated lower levels of intracellular triglycerides than the cells expressing wild-type TSC2 (Figure 5E). Consistent with the mTORC1-dependent increases in PPARgamma expression detected in Tsc2-deficient MEFs and 3T3-L1 cells (Figure 4), a corresponding decrease in PPARgamma levels was observed in the TSC2 and TSC2-5A-reconstituted MEFs at the time of differentiation (Figure 5F). Therefore, despite robust restoration of insulin signaling to Akt in the TSC2-5A-reconstitutied cells (Figure 5B), loss of the ability of Akt to phosphorylate TSC2 and activate mTORC1 in these cells leads to decreased adipocyte differentiation. These findings demonstrate that TSC2 phosphorylation is a major contributing factor to the essential role of Akt in adipogenesis.
###end p 58
###begin title 59
###xml 30 38 <span type="species:ncbi:9606">patients</span>
Renal angiomyolipoma from TSC patients contain fat and smooth muscle-like cells exhibiting elevated levels of mTORC1 signaling and PPARgamma
###end title 59
###begin p 60
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Karbowniczek1">[49]</xref>
###xml 550 558 550 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g006">Figure 6</xref>
###xml 880 888 880 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g006">Figure 6</xref>
###xml 1155 1163 1147 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006189-g006">Figure 6</xref>
###xml 1433 1438 1421 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 1526 1535 1514 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006189.s006">Figure S4</xref>
###xml 198 206 <span type="species:ncbi:9606">patients</span>
###xml 496 501 <span type="species:ncbi:9606">human</span>
###xml 540 548 <span type="species:ncbi:9606">patients</span>
###xml 1481 1486 <span type="species:ncbi:9606">human</span>
###xml 1635 1643 <span type="species:ncbi:9606">patients</span>
The mTORC1-dependent adipogenic effects of TSC gene disruption in cell culture, described above, are likely to contribute to the aberrant appearance of adipocytes within renal AMLs from TSC and LAM patients. As with the smooth muscle-like cells within AMLs, these adipoctyes display LOH at the TSC1 or TSC2 locus [49], demonstrating that they are part of the neoplastic lesion. To examine the major signaling defects found in cultured TSC-deficient adipocytes in these tumors, we compared normal human adipose tissue to AML tissue from TSC patients (Figure 6). Phospho-S6 staining was detected predominantly in the cytosol of the adipocytes, which is proximal to the cell surface due to the large lipid droplet, and the AML-associated adipose tissue appeared to have elevated levels of phospho-S6. The smooth muscle-like AML cells also exhibit high levels of phospho-S6 staining (Figure 6, bottom sample). Adipocytes from normal fat tissue contained a single focus of PPARgamma staining, indicative of their mononucleated nature. However, the aberrant adipocytes within the AMLs were often multinucleated with each nuclei staining positive for PPARgamma (Figure 6, see higher magnification insets). Interestingly, both the adipose and smooth muscle components of the AMLs displayed elevated levels of nuclear PPARgamma. In support of these immunohistochemistry findings, data from a gene expression array experiment demonstrate that PPARG transcript levels are greatly elevated in human AML samples relative to normal kidney (Figure S4). Therefore, like cell culture models lacking a functional TSC1-TSC2 complex, tumor cells from TSC patients display elevated mTORC1 signaling and PPARgamma expression.
###end p 60
###begin title 61
Elevated mTORC1 signaling and PPARgamma levels in TSC-associated angiomyolipoma.
###end title 61
###begin p 62
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Serial sections of normal human adipose tissue (top) or renal AMLs (middle and bottom) from TSC patients were H&E stained or subjected to immunohistochemistry with anti-phospho-S6 (S235/S236) or anti-PPARgamma, as indicated. Representative regions are shown at 100x magnification, with enlarged (2.5x) insets showing more detail. Red arrows point to a few of the many cells within the field showing nuclear PPARgamma.
###end p 62
###begin title 63
Discussion
###end title 63
###begin p 64
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Rosen3">[72]</xref>
###xml 487 490 483 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Peng1">[1]</xref>
###xml 491 494 487 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Xu1">[4]</xref>
###xml 496 500 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Miki1">[61]</xref>
###xml 502 506 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Fasshauer1">[75]</xref>
###xml 508 512 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Garofalo1">[76]</xref>
###xml 1155 1159 1143 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Cho1">[12]</xref>
###xml 1160 1164 1148 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Kim1">[15]</xref>
###xml 1238 1242 1226 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Sarbassov2">[45]</xref>
###xml 1395 1399 1383 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Cho1">[12]</xref>
###xml 1478 1482 1466 1470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Huang2">[55]</xref>
###xml 1617 1620 1605 1608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc</italic>
While there have been great strides in our understanding of the transcriptional program driving adipocyte differentiation, much less is known regarding upstream signaling pathways instituting hormonal control over the process (reviewed in reference [72]). Amongst critical signaling components downstream of insulin, IRS-1/2 and Akt1/2 have been found previously to be essential for proper upregulation of PPARgamma and induction of adipogenesis in cell culture models (e.g., references [1]-[4], [61], [75], [76]). Our study takes advantage of signaling defects triggered by loss of the TSC1-TSC2 complex to determine the contributions of specific branches downstream of these proteins. In this setting where IRS-1 and IRS-2 levels are decreased and Akt is unresponsive to insulin, we find that mTORC1 activation alone can drive PPARgamma expression and adipogenesis. As a gain of function model for mTORC1, this study with TSC1/2-deficient MEFs and 3T3-L1 preadipocytes provides critical support to previous studies suggesting involvement of mTOR signaling in PPARgamma-driven adipocyte differentiation, which used rapamycin alone to establish this link [12]-[15]. Given that prolonged rapamycin can inhibit mTORC2 assembly and function [45], it is possible that some of the inhibitory effects of rapamycin on differentiation are due to loss of Akt signaling, as detected in at least one study [12]. In cells lacking the TSC1-TSC2 complex, mTORC2 and Akt are already inhibited [55], assuring that the effects of rapamycin on these cells are due to mTORC1 inhibition. Therefore, using rapamycin to inhibit mTORC1 and Tsc gene disruption to activate it, our data strongly indicate that mTORC1 activation is both necessary and sufficient to stimulate PPARgamma expression and adipocyte differentation.
###end p 64
###begin p 65
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Inoki1">[21]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Manning2">[22]</xref>
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Cai1">[74]</xref>
###xml 317 327 317 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Potter1">[73]</xref>
###xml 627 631 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Inoki1">[21]</xref>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Manning2">[22]</xref>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Cai1">[74]</xref>
###xml 686 689 686 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 682 689 682 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 721 725 721 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2</italic>
###xml 833 843 833 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 859 871 859 871 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S939A/T1462A</sup>
###xml 960 992 960 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S939A/S981A/S1130A/S1132A/T1462A</sup>
###xml 2259 2262 2259 2262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Nakae1">[8]</xref>
###xml 317 327 <span type="species:ncbi:7227">Drosophila</span>
###xml 833 843 <span type="species:ncbi:7227">Drosophila</span>
Our study also identifies TSC2 as a critical downstream substrate of Akt in the induction of adipocyte differentiation. Previous studies have identified five distinct sites on TSC2 that are likely phosphorylated by Akt in vivo [21], [22], [74]. Two of these sites (S939 and T1462) are conserved and phosphorylated in Drosophila TSC2 [73], whereas the other three sites (S981, S1130, and S1132) are conserved in all vertebrate versions of TSC2. Previous overexpression studies with phosphorylation-site mutants in otherwise wild-type cells have lead to ambiguous results regarding the relative importance of the different sites [21], [22], [74]. Through the stable reconstitution of Tsc2-/- MEFs with wild-type and mutant TSC2, we find a critical role for the vertebrate-specific sites on TSC2, in addition to those conserved back to Drosophila. While the TSC2S939A/T1462A (TSC2-2A) mutant lead to partial attenuation of mTORC1 signaling, expression of the TSC2S939A/S981A/S1130A/S1132A/T1462A (TSC2-5A) mutant resulted in a complete block in the ability of insulin to stimulate mTORC1 signaling events. Importantly, both wild-type TSC2 and the phosphorylation-site mutants were equally efficient at restoring insulin-stimulated Akt signaling to these cells. Therefore, while it is likely that multiple mechanisms exist for Akt to activate mTORC1 signaling, our studies demonstrate that multi-site phosphorylation of TSC2 is essential for this regulation in MEFs. In support of a role for Akt-mediated phosphorylation of TSC2 in promoting adipocyte differentiation, MEFs reconstituted with the TSC2-5A mutant were severely blunted in their ability to take on an adipocyte morphology and accumulate intracellular triglycerides relative to those reconstituted with wild-type TSC2. The fact that some basal differentiation still occurs in these cells, where mTORC1 signaling is blocked, suggests that reactivation of IRS-1/Akt signaling upon TSC2 reconstitution in this setting might provide an mTORC1-independent input into adipocyte differentiation. Therefore, while our study demonstrates a critical role for the Akt-TSC2-mTORC1 signaling pathway in this process, it is likely that other branches of Akt signaling, such as FOXO1 phosphorylation and inhibition [8], play additional and, perhaps, partially redundant roles in promoting adipogenesis.
###end p 65
###begin p 66
###xml 268 271 264 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Rosen1">[7]</xref>
###xml 623 627 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Kim1">[15]</xref>
###xml 914 919 887 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pparg</italic>
###xml 1202 1205 1156 1159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1198 1205 1152 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tsc2<sup>&#8722;/&#8722;</sup></italic>
###xml 1283 1288 1237 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pparg</italic>
Our study demonstrates close ties between mTORC1 activation and inhibition and corresponding increases and decreases in both mRNA and protein levels of the adipogenic transcription factor PPARgamma, which is both necessary and sufficient for adipocyte differentiation [7]. However, the molecular mechanisms by which signaling pathways regulate PPARgamma levels are poorly understood. Previous studies have found that prolonged rapamycin treatment blocks 3T3-L1 adipocyte differentiation, and this coincides with a decrease in both C/EBPalpha and PPARgamma mRNA and protein levels, with no change in C/EBPbeta or C/EBPdelta [15]. The data presented here demonstrate that mTORC1 activation is sufficient to increase PPARgamma expression, even in the absence of other signaling inputs from Akt. We have also examined the mRNA and protein levels of the other known adipogenic transcription factors, which can regulate Pparg expression. We have detected an increase in C/EBPalpha transcript levels in TSC-deficient adipocytes, but unlike PPARgamma, we have not detected an increase in C/EBPalpha protein levels. Furthermore, C/EBPbeta and C/EBPdelta protein levels are actually lower in differentiating Tsc2-/- MEFs. Therefore, there appears to be an mTORC1-dependent mechanism promoting Pparg transcription.
###end p 66
###begin p 67
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Crino1">[47]</xref>
###xml 432 436 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC1</italic>
###xml 440 444 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TSC2</italic>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Karbowniczek1">[49]</xref>
###xml 823 827 823 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006189-Crino1">[47]</xref>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 169 176 <span type="species:ncbi:9606">patient</span>
###xml 1009 1017 <span type="species:ncbi:9606">patients</span>
Renal AMLs are amongst the most prevalent tumor in TSC and LAM patients and are the source of significant morbidity due to their propensity to hemorrhage [47]. In these patient populations, AMLs can grow to sizes greater than the kidney and occupy large areas of the body cavity. The most unusual characteristic of these tumors is that they are comprised of smooth muscle-like cells and adipocytes, both of which display LOH at the TSC1 or TSC2 locus [49]. The prevailing model for the origins of this tumor is that a mesenchymal precursor cell undergoes a second genetic hit at one of the TSC loci, rendering the cell defective for TSC1-TSC2 complex function and, thereby, activating mTORC1. Following increased growth and proliferation, the progeny of this cell aberrantly differentiate into these mesenchymal cell types [47]. It seems likely that the mTORC1-dependent increase in PPARgamma expression described in this study could account for the abundance of adipocytes in the majority of AMLs from these patients. To this end, we find that both the adipocytes and smooth muscle-like cells in TSC-associated AMLs express high levels of nuclear PPARgamma. The somewhat surprising expression of PPARgamma in the smooth muscle-like cells suggests that either this transcription factor is also involved in the differentiation of this cell type or that, perhaps, the adipose component of the AML is derived from the smooth muscle through a PPARgamma-driven transdifferentiation process. With respect to therapeutics, our findings suggest that PPARgamma agonists, such as the thiazolidinedione rosiglitazone, might futher stimulate the putative TSC-deficient precursor cells to differentiate and, therefore, limit their capacity to proliferate and/or migrate.
###end p 67
###begin p 68
###xml 281 286 <span type="species:ncbi:9606">human</span>
This study adds adipogenesis to the increasingly diverse array of processes to which mTORC1 activity has been attributed. It is clear that the consequences of mTORC1 activation vary significantly in different cell lineages. Therefore, understanding the role of mTORC1 signaling in human development, physiology, and disease requires studies geared toward defining these tissue-specific functions. Such studies are also important to comprehend the systemic effects of mTORC1 inhibitors, which are now being tested as therapeutics for a number of clinical conditions, including TSC and LAM.
###end p 68
###begin title 69
Supporting Information
###end title 69
###begin p 70
Supplemental Materials and Methods
###end p 70
###begin p 71
(0.03 MB DOC)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
Quantitative RT-PCR primers used in this study.
###end p 73
###begin p 74
(0.04 MB DOC)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
MEFs lacking the TSC1-TSC2 complex are defective in Akt signaling. (A, B) Constitutive mTORC1 signaling and insulin-resistant Akt phosphorylation in Tsc1-/- (A) and Tsc2-/- (B) MEFs. Littermate-derived MEFs were serum starved for 16 h and then stimulated with 100- or 830-nM insulin for 15 min prior to lysis and immunoblotting with the indicated antibodies (P-Akt-S473; P-S6-S235/236). (C) Akt-mediated phosphorylation of FOXO1 is defective in Tsc2-/- MEFs. Littermate-derived MEFs were serum starved or grown in full serum overnight prior to lysis and immunoblotting with the indicated antibodies (P-FOXO1-T24). (D) Constitutive localization of FOXO3a to the nucleus in Tsc2-/- cells. GFP-FOXO3a or the Akt phosphorylation site mutant, GFP-FOXO3a-AAA, were transfected into Tsc2+/+ or Tsc2-/- MEFs. GFP fluorescence was then localized in live cells grown in full serum. Representative localization patterns are shown.
###end p 76
###begin p 77
(6.57 MB TIF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
Tsc1-deficient MEFs display an mTORC1-dependent increase in adipogenesis. (A) Greater lipid accumulation following an adipocyte differentiation protocol in Tsc1-/- MEFs relative to littermate-derived Tsc1+/+ MEFs. MEFs of the indicated genotype were induced to differentiate for 8 days, and cells were then stained with Oil Red O. Representative culture dish wells (top) and microscopic fields of view (bottom; scale bars = 25 microm) are shown at the same magnification for each genotype. (B) Tsc1-/- adipocytes have higher levels of intracellular triglyceride than Tsc1+/+ adipocytes. MEFs were induced to differentiate for 8 days in the presence or absence of rapamycin (20 nM). Relative triglyceride levels, normalized to cellular protein content, are shown from three different experiments as the mean+/-SEM. *P<0.01.
###end p 79
###begin p 80
(4.11 MB TIF)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
Rapamycin increases Irs1 and Irs2 transcript levels in Tsc2-/- adipocytes and partially restores IRS-1 protein levels. (A) Tsc2-/- adipocytes were treated for 24 h with rapamycin (20 nM), and Irs1 and Irs2 mRNA levels were measured by quantitative RT-PCR. Values are normalized to untreated controls and are presented as mean+/-SEM. (B) Tsc2+/+ and Tsc2-/- adipocytes were treated as in (A) and immunoblotted for IRS-1 protein levels. Total eIF4E levels are provided as a loading control.
###end p 82
###begin p 83
(2.14 MB TIF)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
###xml 69 77 <span type="species:ncbi:9606">patients</span>
###xml 142 150 <span type="species:ncbi:9606">patients</span>
PPARG mRNA expression is elevated in kidney angiomyolipomas from TSC patients. Normalized PPARG expression levels in AMLs from two individual patients with TSC are shown relative to expression levels in normal kidney.
###end p 85
###begin p 86
(3.58 MB TIF)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 221 226 <span type="species:ncbi:9606">human</span>
We thank Drs. Chih-Hao Lee and Gokhan Hotamisligil for helpful discussions and Khanichi Tape for technical assistance. We thank Dr. David Kwiatkowski for cell lines and constructs. The gene expression array experiment on human TSC-associated AMLs was performed by R.M.S. while an employee at The Rothberg Institute for Childhood Diseases, and we are indebted to the Institute for their work in this area.
###end p 88
###begin title 89
References
###end title 89
###begin article-title 90
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2.
###end article-title 90
###begin article-title 91
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
PKBalpha is required for adipose differentiation of mouse embryonic fibroblasts.
###end article-title 91
###begin article-title 92
Isoform-specific regulation of adipocyte differentiation by Akt/protein kinase Balpha.
###end article-title 92
###begin article-title 93
Protein kinase B/AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation.
###end article-title 93
###begin article-title 94
Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation.
###end article-title 94
###begin article-title 95
AKT/PKB signaling: navigating downstream.
###end article-title 95
###begin article-title 96
PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth.
###end article-title 96
###begin article-title 97
The forkhead transcription factor Foxo1 regulates adipocyte differentiation.
###end article-title 97
###begin article-title 98
FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity.
###end article-title 98
###begin article-title 99
TOR signaling in growth and metabolism.
###end article-title 99
###begin article-title 100
###xml 19 24 <span type="species:ncbi:9606">human</span>
Rapamycin inhibits human adipocyte differentiation in primary culture.
###end article-title 100
###begin article-title 101
Regulation of adipocyte differentiation and insulin action with rapamycin.
###end article-title 101
###begin article-title 102
Rapamycin-sensitive phase of 3T3-L1 preadipocyte differentiation after clonal expansion.
###end article-title 102
###begin article-title 103
Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1.
###end article-title 103
###begin article-title 104
regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis.
###end article-title 104
###begin article-title 105
Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells.
###end article-title 105
###begin article-title 106
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity.
###end article-title 106
###begin article-title 107
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.
###end article-title 107
###begin article-title 108
The two TORCs and Akt.
###end article-title 108
###begin article-title 109
A complex interplay between Akt, TSC2 and the two mTOR complexes.
###end article-title 109
###begin article-title 110
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.
###end article-title 110
###begin article-title 111
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/Akt pathway.
###end article-title 111
###begin article-title 112
Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.
###end article-title 112
###begin article-title 113
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.
###end article-title 113
###begin article-title 114
Rheb promotes cell growth as a component of the insulin/TOR signaling network.
###end article-title 114
###begin article-title 115
###xml 68 78 68 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 68 78 <span type="species:ncbi:7227">Drosophila</span>
Rheb is an essential regulator of S6K in controlling cell growth in Drosophila.
###end article-title 115
###begin article-title 116
Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.
###end article-title 116
###begin article-title 117
Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins.
###end article-title 117
###begin article-title 118
Identification of a proline-rich Akt substrate as a 14-3-3 binding partner.
###end article-title 118
###begin article-title 119
PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase.
###end article-title 119
###begin article-title 120
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
###end article-title 120
###begin article-title 121
PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex.
###end article-title 121
###begin article-title 122
The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.
###end article-title 122
###begin article-title 123
PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis.
###end article-title 123
###begin article-title 124
Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation.
###end article-title 124
###begin article-title 125
PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding.
###end article-title 125
###begin article-title 126
Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity.
###end article-title 126
###begin article-title 127
Restraining PI3K: mTOR signalling goes back to the membrane.
###end article-title 127
###begin article-title 128
Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway.
###end article-title 128
###begin article-title 129
A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.
###end article-title 129
###begin article-title 130
Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
###end article-title 130
###begin article-title 131
Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2.
###end article-title 131
###begin article-title 132
Rapamycin partially prevents insulin resistance induced by chronic insulin treatment.
###end article-title 132
###begin article-title 133
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.
###end article-title 133
###begin article-title 134
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.
###end article-title 134
###begin article-title 135
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration.
###end article-title 135
###begin article-title 136
The tuberous sclerosis complex.
###end article-title 136
###begin article-title 137
Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.
###end article-title 137
###begin article-title 138
###xml 27 35 <span type="species:ncbi:9606">patients</span>
Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures.
###end article-title 138
###begin article-title 139
Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.
###end article-title 139
###begin article-title 140
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells.
###end article-title 140
###begin article-title 141
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.
###end article-title 141
###begin article-title 142
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins.
###end article-title 142
###begin article-title 143
Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival defects.
###end article-title 143
###begin article-title 144
The TSC1-TSC2 complex is required for proper activation of mTOR complex 2.
###end article-title 144
###begin article-title 145
Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2.
###end article-title 145
###begin article-title 146
S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt.
###end article-title 146
###begin article-title 147
C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway.
###end article-title 147
###begin article-title 148
The role of glucose metabolites in the activation and translocation of glycogen synthase by insulin in 3T3-L1 adipocytes.
###end article-title 148
###begin article-title 149
Effect of daidzin, genistin, and glycitin on osteogenic and adipogenic differentiation of bone marrow stromal cells and adipocytic transdifferentiation of osteoblasts.
###end article-title 149
###begin article-title 150
Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation.
###end article-title 150
###begin article-title 151
Turnover of the Active Fraction of IRS1 Involves Raptor-mTOR- and S6K1-Dependent Serine Phosphorylation in Cell Culture Models of Tuberous Sclerosis.
###end article-title 151
###begin article-title 152
Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes.
###end article-title 152
###begin article-title 153
###xml 81 86 <span type="species:ncbi:9606">human</span>
Regulation of proteins involved in insulin signaling pathways in differentiating human adipocytes.
###end article-title 153
###begin article-title 154
The GLUT4 glucose transporter.
###end article-title 154
###begin article-title 155
Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus.
###end article-title 155
###begin article-title 156
###xml 77 81 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus.
###end article-title 156
###begin article-title 157
###xml 107 115 <span type="species:ncbi:9606">patients</span>
Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
###end article-title 157
###begin article-title 158
###xml 102 106 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Divergent regulation of the Glut 1 and Glut 4 glucose transporters in isolated adipocytes from Zucker rats.
###end article-title 158
###begin article-title 159
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.
###end article-title 159
###begin article-title 160
TSC2 regulates VEGF through mTOR-dependent and -independent pathways.
###end article-title 160
###begin article-title 161
Adipocyte differentiation from the inside out.
###end article-title 161
###begin article-title 162
Akt regulates growth by directly phosphorylating Tsc2.
###end article-title 162
###begin article-title 163
Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning.
###end article-title 163
###begin article-title 164
Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes.
###end article-title 164
###begin article-title 165
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta.
###end article-title 165
###begin article-title 166
Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN.
###end article-title 166
###begin p 167
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 167
###begin p 168
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by the LAM Foundation (H.H.Z.), the Agency for Science, Technology and Research, Singapore (J.H.), the Tuberous Sclerosis Alliance (K.D.), the American Diabetes Association (B.D.M.), and NIH grants CA120964 (C.L.W. and B.D.M.) and CA122617 (B.D.M.). These funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 168

